newsfilter
← Latest News
PR Newswire·

CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE

TORONTO, Feb. 1, 2022 /PRNewswire/ -- Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to an